Earlier this month, the FDA approved the first Alzheimer’s drug in 18 years. Regardless of whether Aducanumab warranted approval (in case you missed it, it has been controversial), we hope that we are on a path to arresting the progression of Alzheimer’s and — ultimately — finding a cure. …
